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1. ]ntrod~ac,tion 
The h~gh]y po~en~ hepa~ocarcinogen, aflatox~n B 1, 
is well known for prodec~ng bioehemica] lterations 
in ]iwer [ l ,  21. A sin#e injection of  the drug ;inhibits 
in ~/~o prote~n synthesis vdfh~n 30 rnin. The mecha- 
nism, whereby tl~.e carcinogen affects the translational 
process, is in fact complex. Impairment of protein 
syntheNs b~yond 7 hz el%or dosing may be considered 
primmity as a consequence of its inhdbition of ]LNA 
~ynthesis. However, afla/oxin's ~hort-tenn elf  eeL evi- 
denced by mmked inhibition 2 hr aft,or administration, 
cannot be explained by a similar mechanism. Since 
our ~arlier ~esutts suggested direct action by aflatoxin 
B] on polysomes ~3], we have sough~ o further e~uc~- 
date ~5s point by de*ermSning ~.e aflaloxin B t effeel 
~l~ro and in ~ivo on the ab~]i W of  isolated poly- 
sornes ~o incorporate amino acids. 
This paper ~epoxts the in ~ii7"o effec~ of  af~atoxin 
B 1 aud o f  some aflatoxin-defived me,tabNites on the 
syntheE~zing aefivily of  normal ra~ 1iv, or polysomes in 
a cell-fre~ ~5"stem. Under the~ conditions, crystalline 
rfla~o ~xi~ B 1 is coynp]eiely inactive whereas aflatox3n- 
delived ~netabo~tes obtained by enzymic onversion 
of flee myco~oxin me able ~o inl~bit t~anslation i
~i~o. The present restflts upport £he hyp~fl~e.ffm of a 
direct el?oct ofaf latoxin tl 1 de~vatives on the fnn.c- 
~ional ac~vity of polysome~. Moreover, they zN~e the 
problem of the structure of  the active compound and 
its xdlafionship v,Sth the deriva~ve inhibiting :the txans- 
lational pzocess. 
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2. Materials and methods 
Male Wistm ra~s (Commentry s~m~,) weigMng 
abo~t 300 g and fed a balanced semi-synthe~c diet 
were fasted ] 5 hr before k~A]Jng by decapitation. Poly- 
somes were isolated by a prevJous!y repor:ed rood,Sil- 
tation [4] office original mefl~od published by 
B]obel and Potter [5]. The po]ysorna~ stmndard sys- 
tern incorporating amino acid owing to its endoge- 
nous n~essenger .RlqA has been previo=sly ,2escfibed 
[6]. The de~elm~nafion of incoxporated L-[t4C]leu- 
dne was made using paper disks (Whatrnan 3 MM) ac- 
cording ~o Mans and Novelh [7]. 
Microsomes wer~ is~]a~ed from the livers of  tins in- 
je l led imrapedtoneal]y w]hh 3-me~ylcholamhrene 
once a day fo,I 3 consecu~$~e days before killing (2'{) 
mg]kg on the ls,~ day, 10 rng/kg on the 2nd and 3rd 
days). Livezs were homogenized in 9 vo] ofmed.~um 
R (50 rnM Tris-HCl pH 7.4, 3 mM MgC12, G.23 M su- 
crose) and centfifuge~ for 20 rain m 15~00C rpm 
(Spinco J 21, rotor JA 20). The postmi~ochondga~ 
supenaaLant was removed, then cen~r~uged for 60 
ngn a* 50,000 rpm (Spin.co, rotor 50 Ti), in ozder *o 
spin down the nade~osomes. The pellels were s~ored a~ 
_50  °" 
~,~ enzyn~Ac activation of afla~oxin B1 was pal- 
foxed  at 37~; the incubation ll~sk roufi_ne!y ~on- 
rained 5OOpg of aflaloxin B1,20 rng NADFH, and 
mic;osomes equivalem ~o 4 g of  live_r in 50 m] of  me- 
dium R. The fla~ks were ~haken for 45 rain. The n~uix - 
tare was ex~iaclecl 3 ~mes with an eqmfl volume of 
ch!,oroform. Th.e cornbined-solub!e fractions were 
dried ~vifla Na2SO4-and evapoxated-~o :~:r~ness. The- 
iesidue was ~disolved :an various :soi~ents (Tfis-buffex, 
1,2-propane diol, ace tone). 
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Table ~l 
Effect of aflal,0xi~ B~ mad mRa,~oxi~ M~ on L~ ~ilro p,sole~n 
~yn/hesis. 
Table 2 
]~flaSbitoly acti~ty of aflatoxin Ba ,de~adve~ onin ~2tro p~ 
lein ~nthe~is. 
~nal  P~rcenl 
Af/a~.oxin of assay 8-eDen ~ ,~f con~r.o] 
~ ~  B~-dexDed 
~'le,Iaboli~tez* 
B~ ,25 Tris-buffer 1,0I 
B a 55 1,2-Pxopane ~dio] 102 
B 1 IO0 1,2-.I~-c~p,.mae Ctiol I01  
B~ 46 Eihanc;] 97 
M 1 ,~ 7 "~kJ~-D~aS~ 106 
Ma 34 Tzis-bu ffer a00 
lneu~h~tion r ix~'nre co~aL~ined per ~rd .o~ slm~d~rd assay: 0.5 
~,~noa=s ATP, 0. ] ~o les  ,13TP, 3 ~rnoles phosphoeno]pyr~vate, 
25 p~ pyrova~te kina.~e, 5,0 vrno,~es T~js-HC] pH 7.5, ]0 ~a'n~ies 
MN ,(CHzCO~)2, 10O ~meles K'~, 40 ~amoles NaC,I, 9.05 
~mo]es of each ,/9 a~'C-ami-,a'o cid.% 2uCi L-~4,C]Ieuehae, 8 
rng ,~H 5 enzyme, 4.5 A~5O un~s :r~t fiwr polysornes. The Ln- 
eubsl~on 0115 z~I) was z~n 60 xnira ~-~ 37 ~. E~ch exp~rinaen~ 
was ,=onap~d ~o ~'tS o,¢a'l £onno~ ~hSch ¢on~ef l  ~h~ san]e 
amo'arat of ~e ~olven~ a~sed ~o solu~iz~ afla~oxin~ Res,~ats 
aze raean~ of 6 experiments. 
Numbez of n~ra] of P~eam 
prepaxation~ a~say ~o~n~ ol ~on~ro] 
X~ 8 1,2-Pxopmae ~o1 56 
X4 6 ]~flamaoI 73 
X4 l0 E~hmao] 23 
Xa4 7.5 Tris-buf£ex 46. 
Xa4 ~.2 Tzlmbuf£cr ell 
~-~ ,~ Z6 Tris-buffer 72 
* qSae q~anfity of aflmoxin B~-de:~efl compound wss esfi- 
.ma~ed by ~uor~densitometfic ineasuremem ufmg the speci~e 
~co~fficSen~ of afLa~oxLu B a. Incubation cond,~fions wer~e iden- 
aSeal to 'thos~ .desen'bed in ~mble 1. Eae~a experiment was con~- 
pared ~o ~ts own control w]-fich con~dn, ed ~]ae ~ame arnoum of 
*a~a~ solven~ used ~to soltubilZze s:l~- ~tox~'a-der~we.d compounds. Re 
suits are ~ean_~ ot" ,6 ~o 9 de~ermina*ions. 
"]~hin-layer chromatography was carried out on sili- 
ca g.~] coa~ed plates 6G-HR Maehezey-Nage]) using 
c~.croform-acetone .(9:1) for development. 
AGatoxln B a was p~rehased ~'rom M~or  Inc. 
,(3e~sz]'em, Israel) ant] uniformdy labeled 
L.[14C]l.euc~ne from ~_e Commiss ,afiat ~ l"Energ~e 
Atomique {~aehy, France). 






F~g. 1 ~lnoxodensixometrie ~axxni~g ioa'~t~ f t,.az~$x-lay~ 
chrem ~ography pla~e~,ofafla~oxin Brdedv~d meZabolites. 
"iq~,~ ]~ e,~-r chromatography was ear~ie~t,0ut 'on smea ~el- 
.coat. 6,~.~te~ ~'~fing ch~oxo£orm-acetone (9:~) for d~e]~/~ 
,aerie, Y]~aoroden~itometfie det rmiaation wasanad~in a xe- 
.~rding ,Cen~ito.rnexe:r equipped £ox "/In.~rezccn~c nfisrdon a'nea- 
.~ta~e~Tacnl (lZ'hotolnetr~ 5.n1-egrai:eui enzcgLv~cnr Vernon, _ 
~v~ZI.a-'q~) - O: o~g'm; ~:  Ixdn% of ~o~lw~n't;" B 1: ~a-~latoxin B 1 ; 
M 1: ~aqatoxin M 1; A~ B, C~ D~ E; u~m0~m etab01i'te~ (see 
348 " 
,Crysi~Eine ~fl~oxin B I has no effec~ on amino 
~ci,d ineorporafion by th,e po~ysomal s,t~u,d~d sys l~.  
whatever the ~o]~em rased to .dissolve at beSm~ testing 
.(table 1). The foregoing ,:esutt is ~ot too surprising if  
one consi.d~rs that many ,drugs and ca~cm,ogen~ ze-
qafirc metabolic tr.ansformafi.Dn to be active in r i co  
as well as in ~,iwo ~B, 9]. .Along ~.hJs ~e,  it should be 
nosed tha~ pure afla-~oxin ]31 ~dsD com,p]e~]y fai/~ to 
~bi t  ~ ~,~/ro ,b-anzmiption [ 3tO] . In  yi.l-r,o c,DrJve,:rsivn 
of afl~tomn B~ into active derivafiv,e~ by na~crosornal- 
induced enzymes re,sponsib']e for dxug m,e~abolism 
leads ,~,o severa~ compounds: a~atoxin M 1 mad congpo- 
nents A, B, C, D, E ,(~g. ]). T~e aflatoxin-de~'eed 
compounds irdaib~ in ~itro amhao acid incorporation 
~y the pMysomal standard ~stem (table ~2). The in- 
~b i to ry  capaci~ of so-foxme~ ,defrca~2ves sh~ws ~g- 
nificant diffexences fox .successive preparafio~a~, The 
vadabj/ity anay be ,explained as £ollovr~; the quantita- 
tive e~firna*ion, as indicated in table 2, is detemained 
on the ~o-tal chaoroform-sdub]e aflato)Sn derived 
d 
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Tibia 3 
Itequ~em~nls ~o~ conversion of aflai~xin Ba ~o dexiva~es in- 
hi'biting $n ~it~o amino acid incorgorafi~n. 
Tabl~ 4 
Inhibitoxy acfi~d~y of v~Imoxin B a dexiva~-~s on g~ ~$tro p~t>- 
Iein synth,eais as a fanct ien  o f  the so~en't  used. 
]m ~/Yo eon~ersiom ~Zfcct o~/~ ~/yo 
of afh'loxin Ba amino acid incozpo~a~on 
Con%tol* (3130) 
Comple le  system *~ 43 
2~lh:us ax~}atox~ B a 113~ 
Minus rrdcx,osomes ! 01 
Minus N_~PH 9 t 
Heated mie~osorne~ 3 3 O 
The court,el foz in ~/~0 amino acid i~gDrps~ado.~ wa~ fie- 
sere.Led in lab]e t. 
The cD11~lgte SyNIC!II fez alilalOX:ill B l @nve~g~n con-  
tained in !0 ml of medium R: IOD ~ allstoxin B~, 4 nag 
NADPH, miclosomes quiva3ent to0.3 g el livez. 3neuba- 
fions ware ran 45 rain at 37". lncubafian mNmzes were 
expected with cMozofozm 3 times. The po~led ex~rac~ 
v~e~ valaD~a*ed ,o dnrness. The f*sddue was dissolwed in
Tzis~butt'~z. The addition of the lat~er was ch~cked on the 
~clNity of tbc polys~a] standmd system incezparafing 
amen. a~ids. Resalts me na~aus of 6 dete,~mirmti~s. 
*** Microsor~es ~es~spended in n~d.~urn ]1 weze h~d at 30t3 ° 
for 30 rain befeze adding ~to ?_he i,mc,_~bat~on flask. 
fraction usiag arbitrarily the specific coefficient of  
aIlaloxin B~a. Thi~ fraction ac~al ly contains everal 
compolmds; the ~elalive pzopmfion of these com- 
podnds varies for ,the successive batches depending on 
fac2o~s ~ur~ as the enzs,~_,ie activiW of the nficrosomes, 
efficiency o f  aflatoxin convezsion, sens~'tiviry of the 
m olecule~ o ]igh_L stability o f  'the active rnetaboliic in
va ions  solvents, etc.. .  These ~sc~epancies wN disap. 
pea,~ when the acdvity of ~Ae pxeparati,ons can be ex- 
pressed in *ezms o f  concentlati~n "mthe ~nae active 
componenl {see below). W~a*eYe= the variability ob- 
served with xaccessive plepaxa~ons0 it must be poin:tefi 
ou~ thai conversion ofaf ia loxin B3 is s~ct ly  depen- 
dent1 on Ihe presence ,of mie~a~omes and NADPH (table 
3). 
The foregoing results clem]y demonstrate lhaI aria- 
~oxin Bl-defi~,ed naeiabg/ites -Jalaf~ g'~e incorporation 
'of amino acids by nonmfl pol_vsomes, whexeas aflatox- 
hu B I iB coraplctely inactive. T1ae~ i'ind~mgs support 
• e hNpothesis of  a dire c~ and specific ac~on o f  the 
drug on pro,rein Nosynthesis apart f lom its ,effect via 
the impairment o f  "the lranscripfiona! process. Thus, 
'they may accoun,~ fdr "the early and strong iuhibifion 
,observed in ~i~o IS] ; FuI']21~e]" experiments will attempt 
N£1siox'.~ B a- 
de~Y~ d metaboliC:ca 
Nnmbez ~g~ml Pe~cen~ 
of p,zap- of of 
avat~ons- a~y ~o l~nt  oa.r~o~ 
X~a 5.6 a,2-Pzopane di~t 42 
X6a 5.2 Acc~0ne ? 0a 
X6b 8.4 t,2-P~opane diol 3~ 
X~b 30.4 Acetone 86 
~ 8.2 Acetone 97 
E2 6.0 E~ano] 302 
E2 13.0 D'amethyl ~foxy~ic 97 
E~ I 0.3 ] ,2-]~opane dio~ 10 3 
E~ 12 6 Tri~b~ffe~ 7 2 
The po lysom~ slandaxd s3 stern fo_~ amino acid incorpora,.5on 
was ,tescr~efl in"~able L ~ach expatimenl was compact Io 
its ~wn con~xol ~hie~ confined ~he same smounl ~fthe SoB- 
V~n~ used io s~]ubilizc afl~oxin dcrivafiwes. ]%esu]Is axe rne~_s 
of 5 d~errninations. 
The amt~lx~± of a mFJato.~in-[l~l~ved CarSDO~d 9¢aS es~Jl- 
ma~d by fluolodenffHo,nl~c rncam~a-cm~nl x:Kmg ~ specif- 
ic coefficbnt of ai]a~ox~ g~. 
to determine the step o f  *-he tranwlationa~ p o~ss 
which is affeztcd by ~c  ~eactive m~abol i te.  
The presen~ results, however, rai~ s~vera] q~fEs- 
fleas. First, il would Dr, of interest Io know the slr~c- 
turc o f  the t~ agti~e rn~abo]ite. AS of  now, we 
know only what ,5l is not. During M ~i~r0 gonwersiDn 
of  af latox~ B],  Ibm fo~at ion  of  ~hydroxylat~d de,;- 
ira five O.,e. atlatoxin ?~'t) p~edomina~es; *-h3s ~c, le~e 
has no a~don on in ~'/~'o amino acid incorporation 
(laNe 1). Fluolodenii~ometfic aann~ng of ~n-laye~ 
chxama~ography plates reveals, in attrition to ~esid~al 
aflatoxin B 1 and al l , toxin MI ,  lzew ~ino i  spols of un- 
lma~-n compounds ~A ~o E in fig. 1). Th• identifies- 
lion of the l]]tirnale active compound will allow us i,o 
de~erm~.e ~2he a~olule ~oncen'i~afion Of ~he p~ep~a- 
dons and to ~educe ~ahL ~ diffezences in Ihe activity e f  
sug~ssive ba~claes as ~xpressed in table 2. Some p~e- 
t i l I l i l l i t l~ :reslll~ts tla~,re b,~en o]~i~hled ~OnC~l-lX~lg t i l e  
rno lec~i  stn~cluze o f  the active derivative(s). Frac- 
tionati'on of ~h~ to~al dHolofu.~nolo]uble exlla~t ,an 
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a 'sBiea gel ~¢olumn in a ,~hlolofOlm-0fllanO] ~t,em 
(9:8.5: ] .5) xhowa tha,t the ~c~]'~e , onaponen, is elu'~ed 
la~dily, which indl~,ate~ an increase, in ,the hyd~ophihe 
:affinity o f  ~.e m,ol,ecule. Mozeove~, fla.e,ex:len~ 'of in ~itro 
protein ~3mthe~.s in~bi~ion de1~nd.s ,on ~he solv~nl 
~a,sed ~o so!ubilize ~,_e ~esidue ,oblm~ed after ch]om- 
fo lm e ~'apolation ,(~e Materials and meflmd~). The 
aflatox~a derivatives soluble in Tzi>buffe~ are more 
po~em inhibit,ors than those ext~act,ed by- ~ceton,e oI
ethanol .(Iab!e 4). The~ ~e~al*s sugges~ *&m the active 
compo~md~ me anole polar than aflmoxln B~. A simi- 
]at co~clus.~on may be deduced flora GameFs papeI 
concerv~ng the toxicity of afla~ox~n B a deriva*ives on 
~. l~p),Vmu~qum TA ] 530 I t 1]. Ob~.en¢ion o f  the uifi- 
Inane ~aac.iive fOlln o f  dlUga and cilrc~nogens f~equenC- 
ly ~eq~]res a hydzoxylalion reaztion of th~ initial oom- 
p~und [~, 9] ; ~ome~limes an in~e~'ae~a~e tep in. 
volves ~yn~.esis of epoxides which are ve~ highly re- 
at?ice m. o]ecules I 12]. Thu~, ae¢iva~ion o f  aflat,oxin 
B 1 m~, be thoughl io pzoceed thx~ugh a similar 
me~ehan ism. 
A second ,q~estioa~ concerns the, ex~en,~ o which 
the afl~loxin ynelabolJles that inhibR ~lhe in ~iizo 
translm.iona] process, eo,~neide wifl~ flao~ impmfing in 
~i~o protein synthesis. There is asye, no answer  1o 
ihi's question, owning to ~ diffi,cu]~y o f  de}coting this 
produ.cl in isola'ted polysomes. How~wz, experimen~/s 
in progl'ess in our labom,oxy may ~oon pro-ride infor- 
mation on @is proFl,em. 
And Finally, is the derivative flaaI ~hibi~s in vitro 
tral~sla'don iden~iea~ o ~hat wh,~ch blocks/n ~i~o tlan- 
scriplion t13].  P~eliminaly ze~llz obtained by  com- 
paring the inhibitoly acfivi'ty o f  differen~ balch.es o f  
aflal,oxJn-derJwd me*aboli,tes are not as yet ~ondus]ve 
,(resu]l~ to be publk~he,d). Fu~flaer experiments with 
purified pr.epamtions are needed ~t,o ~olve rials problem. 
The resul~ clearly demons~rale the inhibi,~oly ac- 
tion ofa f /a tox in  B 1 flerivatllWeS/n ~,it~o n po lysomal  
~ystems, Fu~thelmOle, ~e  have ~eviden~e demonstrat- 
ing Cn :vSvo defec~ in ~ranslafional efiv~W of  poly- 
somal after aflatoxin B 1 dosi.n~ (unpublished report ) .  
Both findings support file hypofl~eMs .of a di~ec, a~- 
,~on of aflaioxin a~netabo]ite(~) .on polysomes. Fu,~iher 
experiments are now in progress *,o determine the 
s t~¢ i~e of  ~e  ac~ve ~;ompound and ~o define the 
site which is impaired in the tTan~laIion~ machin~Iy. 
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